| 摘要 |
<p>The present invention relates to the use of compounds that bind the neuropeptide Y1 (NPY1) receptor for the preparation of a pharmaceutical composition for the diagnosis or treatment of tumors expressing NPY1 receptors, in particular breast cancer, ovarium cancer and glioblastoma. The invention also relates to the pharmaceutical compositions that contain such compounds.</p> |
